News
Immatics und das MD Anderson Cancer Center gründen Immatics US, Inc....
www.pressebox.de
immatics biotechnologies GmbH,
Immatics US, Inc. wirbt insgesamt über 60 Millionen US$ Gründungskapital ein – das Mutterunternehmen Immatics Biotechno…
Multi-Peptid-Impfstoffe zur individuellen Behandlung von...
publikationen.uni-tuebingen.de
Dissertation_Toni_Weinschenk.pdf MB. PDF. Aufrufstatistik Schließen. URI: http://nbn-resolving.de/urn:nbn:de:bsz:21-opus
onkoserv - der aktuellste und unabhängige deutsche Informationsdienst...
www.onkoserv.de
Onkoserv ist der aktuellste deutsche Informationsdienst für die klinische Onkologie
Neue Angriffspunkte für Impfung gegen Hirntumor – Innovations Report
www.innovations-report.de
... Verona Vass, Steffen Walter, Paul R. Walker, Toni Weinschenk, Harpreet Singh-Jasuja and Pierre-Yves Dietrich. Brain (2012) doi: brain/aws042
Netzwerk-Profile
LinkedIn: Toni Weinschenk | LinkedIn
Toni Weinschenks berufliches Profil anzeigen LinkedIn ist das weltweit größte professionelle Netzwerk, das Fach- und Führungskräften wie Toni Weinschenk ...
Toni Weinschenk User | EIT Health
startups.eithealth.eu
People · Toni Weinschenk. Toni Weinschenk. Editorial(Is this you? Contact us). Tübingen Baden-Württemberg (HQ).
Interessen
IMA901, a multipeptide cancer vaccine, plus sunitinib versus ...
www.em-consulte.com
... Jens Fritsche, PhD, Toni Weinschenk, PhD, Steffen Walter, PhD, Alexandra Kirner, PhD, Harpreet Singh-Jasuja, PhD, Carsten Reinhardt, MD, Tim Eisen, FRCP. › im...
Firmen-Mitarbeiter
Publications Luisa Vonghia
www.uantwerpen.be
... Ulrike Gnad-Vogt, Carsten Reinhardt, Toni Weinschenk, Roberto S. Accolla, Harpreet Singh-Jasuja, Hans-Georg Rammensee, Luigi Buonaguro. › staff › publications
Ausbildung
Combining computer algorithms with experimental approaches permits...
journals.scholarsportal.info
Authors. Markus Schirle · Toni Weinschenk · Stefan Stevanović. Source Information. November 2001, Volume257(Issue1-2)Pages, p.1To Journal of ... › ...
Toni Weinschenk - Biografie
de.marketscreener.com
Founder of Immatics Biotechnologies GmbH and Immatics US, Inc., Toni Weinschenk is Chief Innovation Officer of Immatics NV.
He received a doctorate from...
Bücher
Toni Weinschenk - Acemapwww.acemap.info › authorDetail
www.acemap.info
Toni Weinschenk. University of Tübingen. Medicine · Immunology · Biology · Antigen · Cancer Papers Citations. Citation Trend. Author Map.
AACR 2016: Abstracts American Association for Cancer...
books.google.de
The AACR Annual Meeting is a must-attend event for cancer researchers and the broader cancer community. This year's theme, "Delivering Cures Through...
Peptides: The Wave of the Future: Proceedings of the Second...
books.google.de
This volume contains the proceedings of the Second International Peptide Symposium and the Seventeenth American Peptide Symposium, held on June, 2001, at...
Dokumente zum Namen
SCHATTENBLICK - ONKOLOGIE/1313: Glioblastom - Neue Angriffspunkte für...
www.schattenblick.de
... Jens Fritsche, Peter Lewandrowski, Jennifer Lohr, Hans-Georg Rammensee, Stefan Stevanovic, Claudia Trautwein, Verona Vass, Steffen Walter, Paul R. Walker, Toni Weinschenk
EBSCOhost | | CD8+ T-cell response against MUC1-derived...
web.a.ebscohost.com
Jasmin Dittmann Ж Karin Keller-Matschke. Toni Weinschenk Ж Thomas Kratt Ж Tobias Heck. Horst-Dieter Becker Ж Stefan Stevanovic´.
A Role for a Novel Luminal Endoplasmic Reticulum ...
www.jbc.org
von A Komlosh · · Zitiert von: 50 — Toni Weinschenk. Toni Weinschenk. Affiliations. Search for articles by this author. Niels Emmerich. Niels Emmerich. Affiliations. › abstract
Abstract - ASCO Meeting
meetings.asco.org
... Mercedes Iñarrairaegui, Sven Francque, Tanguy Chaumette, Toni Weinschenk, Carsten Reinhardt, Harpreet Singh, Senta Ulrike Gnad-Vogt ... › abstract
Wissenschaftliche Veröffentlichungen
Patents Assigned to Immatics Biotechnologies GmbH - Justia Patents...
patents.justia.com
Justia - Patents - Patents and Patent Application Resources
Molecular & Cellular Proteomics | July Issue | ScienceDirect.com...
www.sciencedirect.com
· Toni Weinschenk : Article : Download PDF. Article preview. select article Precision Neoantigen Discovery Using Large-scale ...
Kidney cancer vaccine successful in clinical trials -- ScienceDaily
www.sciencedaily.com
Researchers have completed two successful clinical studies using the kidney-cancer vaccine IMA901.
Journal of Neuroimmunology | Vol 160, Issues 1–2, Pages
www.sciencedirect.com
Zhiren Zhang, Toni Weinschenk, Hermann J. Schluesener. Pages : Download PDF. Article preview. select article The effect of Toxoplasma gondii ... › issue
Veröffentlichungen allgemein
RNA editing derived epitopes function as cancer antigens to ...
econpapers.repec.org
von M Zhang · · Zitiert von: 86 — ... Leng Han, Yiu-Huen Tsang, Kathleen Kong, Xiaoyan Xu, Kenneth L. Scott, Harpreet Singh-Jasuja, Greg Lizee, Han Liang, Toni Weinschenk, ... › ReP...
Deamidation within a γ-Gliadin-Derived Peptide Enhances Its ...
link.springer.com
von T Mothes · — Toni Weinschenk. Institute of Clinical Chemistry and Pathobiochemistry, University of Leipzig, Leipzig, Germany. Thomas Mothes, Holm Uhlig & A. A. Osman. › chapter
Uptake, cellular distribution and novel cellular binding proteins of...
link.springer.com
Glioblastomas are the most malignant and most frequent brain tumors and exciting targets of gene and immunotherapy. Despite rapid development of experiment
Artikel & Meinungen
Why Being in a New Field From the Start Can Pay Off in the Long Run
www.labiotech.eu
The field of immuno-oncology has expanded out of all recognition over the last few years. Having co-founded one of the first cancer immunotherapy biotechs
Why Being in a New Field From the Start Can Pay Labiotech
www.labiotech.eu
— Singh co-founded Immatics in with two fellow academics, Toni Weinschenk and Niels Emmerich, while completing a PhD in immunology at the ... › intervie...
TFG - Der Pusher-Thread - für Kritiker verboten! Beiträge pro...
www.wallstreet-online.de
Seite 23 der Diskussion 'TFG - Der Pusher-Thread - für Kritiker verboten!' vom im w:o-Forum 'Nebenwerte Deutschland'.
BMBF-Projektforum Biotechnologie BIOTECHNICA Hannover. Dienstag,
docplayer.org
Targets ... zur Behandlung von Bauchspeicheldrüsenkrebs Toni Weinschenk, Lonza AG, Köln 12:40 Neuartiges Anzucht- und Screeningsystem für ...
Sonstiges
Danielle McMullin, RNlinkedin.com
www.linkedin.com
Toni Weinschenk. Stuttgart Region · Connect · Kristen McMullen. Registered Nurse at Rochester Regional Health Acute Stroke Unit Webster, NY.
Francesco Di Lauro - Postdoctoral Researcherlinkedin.com
www.linkedin.com
Toni Weinschenk. Stuttgart Region · Fausta Desantis. LM in Fisica dei Biosistemi presso Sapienza Università di Roma, attualmente dottoranda presso IIT. Rome ...
Mark Studebaker - Hudson, Ohio, United Stateslinkedin.com
www.linkedin.com
Toni Weinschenk. Stuttgart Region · Connect. Explore collaborative articles. We're unlocking community knowledge in a new way. Experts add insights directly ...
Sherry Brosnahan - President - Context Communicationslinkedin.com
www.linkedin.com
Toni Weinschenk. Stuttgart Region · Mark Studebaker. Retired after 33 years as a Medical Director in Managed Care. Hudson, OH · Sherilee Backman.
Toni Weinschenk | LinkedIn
www.linkedin.com
View Toni Weinschenk's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Toni Weinschenk discover ...
Novel T-cell Targets for Cancer Immunotherapies - ppt video online...
slideplayer.com
Immatics Biotechnologies (Germany) An established company dedicated to off-the-shelf cancer immunotherapies Founded in as a spin-out from the University of Tuebingen, Germany by Harpreet Singh, Toni Weinschenk, Hans-Georg Rammensee et al. Since Immatics Biotechnologies GmbH has: Raised ...
Immatics N.V. (IMTX) Company Profile & Facts - Yahoo Finance
finance.yahoo.com
Dr. Toni Weinschenk Ph.D. Co-Founder & Chief Innovation Officer, N/A, N/A, Mr. Arnd Christ MBA, Chief Financial Officer, N/A, N/A, › quote
Immatics N.V. (IMTX) Company Profile & Facts - Yahoo Financeca.finance.yahoo.com › quote › pr...
ca.finance.yahoo.com
Dr. Toni Weinschenk Ph.D. Co-Founder & Chief Innovation Officer, N/A, N/A, Mr. Thomas Ulmer, Chief Financial Officer, N/A, N/A, Ms. Jessica Mosby ...
Proffesor . Toni Weinschenk, | Immatics Biotechnologies | Germany
biography.omicsonline.org
Over the past two decades, Dr Weinschenk has been active in the field of cancer immunology. At Immatics Biotechnologies GmbH, Dr Weinschenk heads..
Toni Weinschenk - Biographie
www.zonebourse.com
Founder of Immatics Biotechnologies GmbH and Immatics US, Inc., Toni Weinschenk is Chief Innovation Officer of Immatics NV.
He received a doctorate from...
Toni Weinschenk | Immatics Biotechnologies | Germany
biography.omicsonline.org
Toni Weinschenk co-founded Immatics Biotechnologies GmbH during his PhD studies and is the creator of the XPRESIDENT® target discovery engine for...
Immatics-Gründer nun CEO - transkript
transkript.de
Wissenschaftsvorstand Harpreet Singh übernahm im Juli die Position des CEOs bei der Immatics Biotechnologies GmbH.
immatics gewinnt den 29. Innovationspreis der deutschen Wirtschaft
www.gesundheitsindustrie-bw.de
Die immatics biotechnologies GmbH aus Tübingen hat den 29. Innovationspreis der deutschen Wirtschaft in der Kategorie „Start-Up“ gewonnen. immatics wurde unter...
Neue Angriffspunkte für Impfung gegen Hirntumor
www.gesundheitsindustrie-bw.de
Krebsforscher aus Heidelberg, Genf und Tübingen sind in der Erforschung eines äußerst aggressiven Hirntumors, des Glioblastoms, einen großen Schritt...
sortiert nach Relevanz / Datum